| 17 | | Preparation by w/p identified in our THT proposal: \\ |
| 18 | | 1 // Outline Conceptual Design Report for the PoP biological-assessment facility // \\ |
| 19 | | Preparation should include articulation of key USPs for LhARA and development of experimental simulation activity independent of the fate of the THT proposal. \\ |
| 20 | | 2 // Proton- and ion-acoustic imaging // \\ |
| 21 | | Preparation should include development of simulation activity and development of proposal independent of the fate of the THT proposal. |
| 22 | | 3 // Evaluation of the benefits of the initiative & optimisation of the R&D programme // \\ |
| 23 | | Preparation should include development of first steps in the necessary programme now, independent of the fate of the THT proposal. |
| | 17 | // __ Development of radiobiology programme and articulation of LhARA USPs: __ **J. Parsons, A. Giacca** // |
| 32 | | 4. ** DoNM **: |
| 33 | | * 10Nov20; 14:00 GMT |
| | 24 | // __ Development of next steps in LhARA accelerator R&D programme: __ **C. Whyte, J. Pasternak** // |
| | 25 | |
| | 26 | |
| | 27 | 4. ** Summary/outreach documents: ** |
| | 28 | * [raw-attachment:2020-11-16-LhARA-mission.pdf Mission statement]: S. Green, A. Giacca, F.Jamieson, K.Long |
| | 29 | * [raw-attachment:2020-11-16:LhARA-timeline.pdf Timeline: today to clinical system]: K.Long, T.Kolkalova-Wheldon \\ |
| | 30 | * PPI Strategy: H.Hall, G.Jones, \\ |
| | 31 | * Industrial strategy: F.Jamieson, S.Towe \\ |
| | 32 | * Stakeholder plan: P. Price, S.Green, K. Long |
| | 33 | |
| | 34 | 5. ** DoNM **: |
| | 35 | * 24Nov20; 14:00 GMT |
